Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The clinical value of foetal-cell implantation in the treatment of Parkinson's disease is still unknown, but this has not stopped the rich and desperate from seeking treatment wherever in the world they can, particularly in countries where there are few ethical controls.
Parkinson's is a neurological disorder which disrupts voluntary physical movement, but leaves the mind untouched. Each year there are15,000 new cases in Britain, with the elderly most usually affected.
The symptoms may start with tremor or shaking in one hand, arm or leg. As the disease progresses, it affects both sides of the body, causing stiffness and weakness all over; a shuffling walk that may break into uncontrollable, tiny, running steps; constant trembling of the hands and head shaking, and a rigid, stooped posture. In some patients, speech becomes hesitant. Eventually, all physical actions become difficult.The cause is premature death of nerve cells in the brain, which produce a chemical known as dopamine. Treatment with a synthetic form of this chemical, levadopa, relieves symptoms for a time but increasingly large doses are needed.
The pressure for an alternative treatment has been intense. It was hoped that transplanting one of the patient's own adrenal glands into the brain so that it would produce dopamine might work. Between 1982 and 1989, 30 patients received such transplants but results were disappointing.
In 1988, Edward Hitchcock, Professor of Neurosurgery at Birmingham University, pioneered the use of spontaneously aborted foetal cells, implanting them into the brains of patients in the hope that they would produce dopamine. Some clinical improvement was reported. However, the Parkinson's Disease Society says that full assessment of this technique is 5 to 10 years away.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments